We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ims Maxims | LSE:IMX | London | Ordinary Share | GB00B3KKWM62 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.75 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:4206Q IMS Maxims PLC 01 October 2003 PRESS RELEASE IMS MAXIMS PLC 1 October 2003 IMS MAXIMS PLC wins contract to upgrade Hospitals and Health Boards across Ireland to Windows-based PAS In a key initiative the Health Board Executive (HeBE) in Ireland has signed a contract with IMS MAXIMS plc to upgrade their existing PAS (Patient Administration System) to facilitate healthcare provision across Ireland in the migration towards integrated electronic patient records. Owned by the Department of Health & Children and used by 48 hospitals in the Midland and Mid Western Health Boards plus the Eastern Regional Health Authority, the new PAS functionality will include front-end Windows applications and an upgrade to state-of-the-art relational database technology. In Phase One the PAS will migrate onto Oracle from its current older file structure plus new Bed Management and Discharge Management applications, operating in Microsoft Windows, will be added. Approximately 100 management reports will be redeveloped to run in the new environment, which will make it much easier to meet any future information extraction and reporting needs. Phase Two, which is planned as an immediate follow-on, will replace the existing character-based Admission/Discharge/ Transfer (ADT) modules with Windows functionality. This will make it possible to add a range of leading clinical applications such as those developed by IMS in collaboration with numerous hospitals across Ireland and the UK. Denis Doherty, Director of HeBE, comments: "In the current situation, where many demands are competing for scarce financial resources, I am delighted that the modifications to the Irish PAS will provide an extremely cost effective way forward for Irish Hospitals and Health Boards. The development will ensure we have an excellent platform on which to base any future plans for integrated systems that deliver improved patient care." Brian Ennis, Managing Director of IMS MAXIMS plc adds: "I am very pleased to have finalised this agreement. As a result of the work now underway, the Irish PAS will migrate to the most current of technologies, including web capability. This will ensure that user hospitals can easily add applications that deliver hospital and community-wide Electronic Health Records (EHR). It will now be possible to operate in a mixed environment, keeping older, character-based terminals where necessary and adding advanced Windows-based or web-enabled applications as appropriate." Denis Doherty, Director of HeBE, concludes: "This imaginative project will extend both the life and the functionality of our PAS. At the same time it will eliminate the characteristics that have restricted our ability to add integrated applications to support the evolving needs of a modern Health Service." Contacts: Brian Ennis Ann Braham Managing Director Marketing Consultant IMS MAXIMS plc Ann Walls Associates Tel: +353 1 284 0555 01558 668582 This press announcement has been issued by Insinger de Beaufort on behalf of IMS Maxims plc Insinger de Beaufort is a subsidiary of Bank Insinger de Beaufort. Authorised and regulated by the Financial Services Authority Registered in England and Wales No. 2582230 This information is provided by RNS The company news service from the London Stock Exchange END CNTEASEFEDNDFFE
1 Year Ims Maxims Chart |
1 Month Ims Maxims Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions